摘要
目的:通过Meta分析评价疾病特异性移动健康软件对2型糖尿病病人健康管理效果的影响。方法:计算机检索PubMed、EMbase、the Cochrane Library、CINAHL、万方数据库和中国知网数据库中有关疾病特异性移动健康软件对2型糖尿病病人健康管理效果的随机对照试验,检索时限为建库至2021年12月。经质量评价后,采用RevMan 5.4软件进行Meta分析。结果:共纳入12篇文献。Meta分析结果显示,基于疾病特异性移动健康应用软件可显著降低2型糖尿病病人的糖化血红蛋白[MD=-0.39,95%CI(-0.51,-0.28),Z=6.70,P<0.00001],提高病人服药依从性。但在改善病人体质指数[MD=-0.08,95%CI(-0.37,0.21),Z=0.52,P=0.60]、总胆固醇水平[SMD=-0.07,95%CI(-0.22,0.08),Z=0.94,P=0.35]、收缩压[MD=2.32,95%CI(-0.22,4.86),P=0.07]及舒张压[MD=0.88,95%CI(-0.71,2.47),P=0.28]方面差异无统计学意义。结论:现有证据表明,疾病特异性移动健康软件可降低病人糖化血红蛋白水平、提升其服药依从性,但在改善病人血压、体质指数及总胆固醇水平上效果不显著,后期需开展更多临床高质量研究进一步验证其临床效果。
Objective:To evaluate the effect of disease-specific mHealth software on the health management effect of type 2 diabetes patients(T2DM)by Meta-analysis.Methods:Randomized controlled trials on the health management effect of patients with T2DM were retrieved frond PubMed,EMbase,the Cochrane Library,CINAHL,WanFang Database and CNKI.The retrieval time was from the establishment of databases to December,2021.After the quality evaluation,Meta-analysis was performed using RevMan 5.4 software.Results:A total of 12 articles were included,and the Meta-ananlysis showed that disease-specific mHealth APP can significantly reduce glycated hemoglobin in patients with T2DM[MD=-0.39,95%CI(-0.51,-0.28),Z=6.70,P<0.00001],and improve patient medication compliance.However,the difference in improving the patient′s body mass index[MD=-0.08,95%CI(-0.37,0.21),Z=0.52,P=0.60],total cholesterol[SMD=-0.07,95%CI(-0.22,0.08),Z=0.94,P=0.35],systolic pressure[MD=2.32,95%CI(-0.22,4.86),P=0.07]and diastolic pressure[MD=0.88,95%CI(-0.71,2.47),P=0.28]were not statistically significant.Conclusion:Current evidence suggests that disease specific mobile health software can reduce patients′glycated hemoglobin levels and improve their medication compliance,but its effect on improving patients′blood pressure,body mass index,and total cholesterol levels is not significant.More high-quality clinical studies are needed to further validate its clinical efficacy in the future.
作者
李梦文
魏梦瑶
LI Mengwen;WEI Mengyao(Shaanxi Provincial People′s Hospital,Shaanxi 710068 China)
出处
《循证护理》
2023年第12期2122-2128,共7页
Chinese Evidence-Based Nursing
基金
陕西省2022年科技发展孵化基金项目,编号:2022HL-01。
